FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

39483811000001104: Gliclazide 40mg tablets (Medreich Plc) 28 tablet 2 x 14 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 14-Apr 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1122781000001110 Gliclazide 40mg tablets (Medreich Plc) 28 tablet 2 x 14 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1122791000001112 Gliclazide 40mg tablets (Medreich Plc) 28 tablet 2 x 14 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Gliclazide 40mg tablets (Medreich Plc) 28 tablet 2 x 14 tablets Is a Gliclazide 40mg tablets 28 tablet true Inferred relationship Existential restriction modifier
Gliclazide 40mg tablets (Medreich Plc) 28 tablet 2 x 14 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Gliclazide 40mg tablets (Medreich Plc) 28 tablet 2 x 14 tablets Has AMP Gliclazide 40mg tablets (Medreich Plc) true Inferred relationship Existential restriction modifier
Gliclazide 40mg tablets (Medreich Plc) 28 tablet 2 x 14 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Gliclazide 40mg tablets (Medreich Plc) 28 tablet 2 x 14 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Gliclazide 40mg tablets (Medreich Plc) 28 tablet 2 x 14 tablets Has excipient Lactose false Inferred relationship Existential restriction modifier
Gliclazide 40mg tablets (Medreich Plc) 28 tablet 2 x 14 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Gliclazide 40mg tablets (Medreich Plc) 28 tablet 2 x 14 tablets Has specific active ingredient Gliclazide true Inferred relationship Existential restriction modifier
Gliclazide 40mg tablets (Medreich Plc) 28 tablet 2 x 14 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Gliclazide 40mg tablets (Medreich Plc) 28 tablet 2 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Gliclazide 40mg tablets (Medreich Plc) 28 tablet 2 x 14 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Gliclazide 40mg tablets (Medreich Plc) 28 tablet 2 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Gliclazide 40mg tablets (Medreich Plc) 28 tablet 2 x 14 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start